Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.468
Neutral
RSI(14)
61.509
Neutral
STOCH(KDJ)(9,3,3)
71.547
Buy
ATR(14)
2.322
High Vlolatility
CCI(14)
214.485
Overbought
Williams %R
24.394
Buy
TRIX(12,20)
0.150
Sell
StochRSI(14)
91.050
Buy
Globe Life Inc
GL142.270USD
-0.220-0.15%
Close 09/12, 16:00（ET）Quotes delayed by 15 min
11.53BMarket Cap
10.82P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-12Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
13
analysts
Buy
Current Rating
160.200
Target Price
+12.60%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Globe Life Inc. is an insurance holding company. The Company's primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, and intensive care products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It has four segments: life insurance, supplemental health insurance, annuities and investments. Life insurance segment’s products include traditional whole life and term life insurance.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 19.72.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 7.90%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 7.90%.
Overvalued
The company’s latest PE is 11.30, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 70.94M shares, decreasing 11.04% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 10.26M shares of this stock.
Financial Health
Currency: USD Updated：2025-09-12The company's current financial score is 7.55, which is higher than the Insurance industry's average of 6.32. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.48B, representing a year-over-year increase of 4.54%, while its net profit experienced a year-over-year increase of 0.14%.
Score
Financials
6.30
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.69
Operational Efficiency
7.55
Growth Potential
7.21
Shareholder Returns
9.01
Company Valuation
Currency: USD Updated：2025-09-12The company’s current valuation score is 2.60, which is lower than the Insurance industry's average of 4.09. Its current P/E ratio is 11.16, which is -9.97% below the recent high of 10.05 and 12.70% above the recent low of 9.74.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 16/112
No Data
Earnings Forecast
Currency: USD Updated：2025-09-12The company’s current earnings forecast score is 7.54, which is higher than the Insurance industry's average of 7.17. The average price target for Globe Life Inc is 153.50, with a high of 188.00 and a low of 145.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
13
analysts
Buy
Current Rating
160.200
Target Price
+12.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
20
Total
8
Median
8
Average
Company name
Ratings
Analysts
Globe Life Inc
GL
13
Prudential Financial Inc
PRU
17
MetLife Inc
MET
17
Corebridge Financial Inc
CRBG
15
Aflac Inc
AFL
15
Principal Financial Group Inc
PFG
14
1
2
3
4
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-12The company’s current price momentum score is 8.80, which is higher than the Insurance industry's average of 8.31. Sideways: Currently, the stock price is trading between the resistance level at 144.73 and the support level at 135.51, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
140.922
Buy
MA10
140.634
Buy
MA20
139.726
Buy
MA50
134.063
Buy
MA100
127.734
Buy
MA200
123.134
Buy
Institutional Confidence
Currency: USD Updated：2025-09-12The company’s current institutional recognition score is 7.00, which is lower than the Insurance industry's average of 7.84. The latest institutional shareholding proportion is 87.56%, representing a quarter-over-quarter increase of 1.18%. The largest institutional shareholder is The Vanguard, holding a total of 10.26M shares, representing 12.67% of shares outstanding, with 2.45% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Wellington Management Company, LLP
State Street Global Advisors (US)
Geode Capital Management, L.L.C.
Invesco Advisers, Inc.
Dimensional Fund Advisors, L.P.
Norges Bank Investment Management (NBIM)
1
2
Risk Assessment
Currency: USD Updated：2025-09-12The U.S. Dollar Index is currently in a neutral state, which has a minor effect on the Insurance mixed industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 6.41, which is higher than the Insurance industry's average of 5.26. The company's beta value is 0.56. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.55
VaR
+2.47%
240-Day Maximum Drawdown
+14.88%
240-Day Volatility
+32.28%
Return
Best Daily Return
60 days
+6.79%
120 days
+8.24%
5 years
+20.17%
Worst Daily Return
60 days
-3.69%
120 days
-8.07%
5 years
-53.14%
Sharpe Ratio
60 days
+2.67
120 days
+0.85
5 years
+0.50
Risk Assessment
Maximum Drawdown
240 days
+14.88%
3 years
+61.71%
5 years
+61.71%
Return-to-Drawdown Ratio
240 days
+2.00
3 years
+0.15
5 years
+0.16
Skewness
240 days
+0.14
3 years
-10.01
5 years
-9.56
Volatility
Realised Volatility
240 days
+32.28%
5 years
+37.15%
Standardised True Range
240 days
+2.10%
5 years
+1.68%
Downside Risk-Adjusted Return
120 days
+114.22%
240 days
+114.22%
Maximum Daily Upside Volatility
60 days
+21.95%
Maximum Daily Downside Volatility
60 days
+16.21%
Liquidity
Average Turnover Rate
60 days
+0.76%
120 days
+0.80%
5 years
--
Turnover Deviation
20 days
-39.50%
60 days
-36.06%
120 days
-32.92%
Peer Comparison
Currency: USD Updated：2025-09-12Globe Life Inc
GL
7.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hci Group Inc
HCI
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
MetLife Inc
MET
8.03 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Unum Group
UNM
7.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AXIS Capital Holdings Ltd
AXS
7.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Arch Capital Group Ltd
ACGL
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
